Volume 138, Issue 2, Pages 522-530 (February 2010) Screening and Early Treatment of Migrants for Chronic Hepatitis B Virus Infection Is Cost-Effective  Irene K. Veldhuijzen, Mehlika Toy, Susan J.M. Hahné, G. Ardine De Wit, Solko W. Schalm, Robert A. de Man, Jan Hendrik Richardus  Gastroenterology  Volume 138, Issue 2, Pages 522-530 (February 2010) DOI: 10.1053/j.gastro.2009.10.039 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 ICER for screening in univariate sensitivity analyses for the lower and upper boundaries of the estimates related to prevalence, the screening program, and patient management. Gastroenterology 2010 138, 522-530DOI: (10.1053/j.gastro.2009.10.039) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 ICER for screening in multivariate sensitivity analyses for most favorable (slower progression) and least favorable (faster progression) scenarios of the estimates related to treatment effectiveness and disease progression in natural history. *The least favorable scenario, with faster disease progression, was assessed by applying the low progression rates for spontaneous or sustained virologic response with the high ranges of disease progression and emergence of resistance and the low ranges for the utility estimates. †The most favorable scenario, with slower disease progression, was assessed by applying the high range of progression to spontaneous or sustained virologic response, the low ranges for estimates of disease progression and emergence of antiviral resistance, and the high ranges for the utility estimates. Gastroenterology 2010 138, 522-530DOI: (10.1053/j.gastro.2009.10.039) Copyright © 2010 AGA Institute Terms and Conditions